UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039147
Receipt number R000044647
Scientific Title A multicenter prospective observational study on the structured parenteral opioid intervention for dyspnea in terminally-ill cancer patients
Date of disclosure of the study information 2020/01/20
Last modified on 2022/01/16 08:45:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter prospective observational study on the structured parenteral opioid intervention for dyspnea in terminally-ill cancer patients

Acronym

A multicenter prospective observational study on the structured parenteral opioid intervention for dyspnea in terminally-ill cancer patients

Scientific Title

A multicenter prospective observational study on the structured parenteral opioid intervention for dyspnea in terminally-ill cancer patients

Scientific Title:Acronym

A multicenter prospective observational study on the structured parenteral opioid intervention for dyspnea in terminally-ill cancer patients

Region

Japan


Condition

Condition

Advanced cancer

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To describe the practice of a structured parenteral opioid intervention for dyspnea in terminally-ill cancer patients

Basic objectives2

Others

Basic objectives -Others

To explore outcomes of a structured parenteral opioid intervention for dyspnea in terminally-ill cancer patients.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The percentage of patients who receive a structured parenteral opioid intervention at 24 (18-30) hours after the initiation of the intervention for dyspnea

Key secondary outcomes

The percentage of the utilization of a structured parenteral opioid intervention, achievement of treatment goals, contents of concurrent treatment such as increase and/or switching of opioids and benzodiazepines, dyspnea intensity, communication capacity and consciousness level, adverse events and dose-limiting toxicities, etc.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Hospitalized patients with the age of 18 or greater
2) Patients diagnosed with locally advanced or metastatic cancer
3) Patients started on the continuous administration of parenteral opioids for dyspnea (IPOS/STAS of 2 or greater)
4) Patients receiving care by palliative care specialist(s) at a palliative care unit or palliative care team
5) ECOG Performance Status 3 or 4
6) Communication Capacity Scale (CCS), item 4 of 2 or lower

Key exclusion criteria

1) Patients who will receive treatent for dyspnea that clearly has no direct pathophysiological association with cancer
2) Patients who are planning to undergo interventions that would change symptom intensity during a short period within 3 days.
3) Patient or family decline to participation

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Masanori
Middle name
Last name Mori

Organization

Seirei Mikatahara General Hospital

Division name

Palliative and Supportive Care Division

Zip code

433-8558

Address

3453 Mikataharacho, Kita-ku, Hamamatsu

TEL

0534361251

Email

masanori.mori@sis.seirei.or.jp


Public contact

Name of contact person

1st name Masanori
Middle name
Last name Mori

Organization

Seirei Mikatahara General Hospital

Division name

Palliative and Supportive Care Division

Zip code

433-8558

Address

3453 Mikataharacho, Kita-ku, Hamamatsu

TEL

0534361251

Homepage URL


Email

masanori.mori@sis.seirei.or.jp


Sponsor or person

Institute

Seirei Mikatahara General Hospital

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour, and Welfare
Japan Hospice Palliative Care Foundation

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Seirei Mikatahara General Hospital

Address

3453 Mikataharacho, Kita-ku, Hamamatsu

Tel

0534361251

Email

masanori.mori@sis.seirei.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 01 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 12 Month 30 Day

Date of IRB

2020 Year 01 Month 20 Day

Anticipated trial start date

2020 Year 01 Month 20 Day

Last follow-up date

2021 Year 06 Month 30 Day

Date of closure to data entry

2021 Year 10 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

Seirei Mikatahara General Hospital serves as the central site of this multicenter study.


Management information

Registered date

2020 Year 01 Month 14 Day

Last modified on

2022 Year 01 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044647


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name